# Naprelan

NDC: 24979-250
Generic name: Naproxen Sodium
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20251231

FDA application: NDA020353

## Active ingredients

- NAPROXEN SODIUM: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24979-250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24979-250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8a51c9a-488e-4377-a041-436f6a2f8893